Thursday 2 October 2003
Epigenetic silencing can mimic genetic mutation by abolishing expression of a gene.
Epimutations in cancer
Most (epi)mutations in cancers are specific to particular tumours or occur at specific stages of development, cell differentiation or tumorigenesis.
Simple molecular mechanisms, such as tissue-restricted gene expression, seem to explain these associations only in rare cases. Instead, the specificity of (epi)mutations is probably due to the selection of a restricted spectrum of genetic changes by the cellular environment.
In some cases, the resulting functional defects might be constrained to be neither too strong nor too weak for tumour growth to occur; that is, they lie within a ’window’ that is permissive for tumorigenesis.
MLH1 germline epimutations in HNPCC syndrome and DNA mismatch repair deficiency (#15064764#)
Sieber OM, Tomlinson SR, Tomlinson IP. Tissue, cell and stage specificity of (epi)mutations in cancers. Nat Rev Cancer. 2005 Aug;5(8):649-55. PMID: #16056260#